Critical Care
(Sep 2020)
Fibrin-derived peptide Bβ15-42 (FX06) as salvage treatment in critically ill patients with COVID-19-associated acute respiratory distress syndrome
- Elisabeth H. Adam,
- Benedikt Schmid,
- Michael Sonntagbauer,
- Peter Kranke,
- Kai Zacharowski,
- Patrick Meybohm
Affiliations
- Elisabeth H. Adam
- Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe-University
- Benedikt Schmid
- Department of Anaesthesiology and Critical Care, University Hospital Wuerzburg, Julius-Maximilians-University
- Michael Sonntagbauer
- Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe-University
- Peter Kranke
- Department of Anaesthesiology and Critical Care, University Hospital Wuerzburg, Julius-Maximilians-University
- Kai Zacharowski
- Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe-University
- Patrick Meybohm
- Department of Anaesthesiology and Critical Care, University Hospital Wuerzburg, Julius-Maximilians-University
- DOI
-
https://doi.org/10.1186/s13054-020-03293-8
- Journal volume & issue
-
Vol. 24,
no. 1
pp.
1
– 4
WeChat QR code
